HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria treated with anti-tumor 1,4-anthracenediones.

Abstract
Since synthetic analogs of 1,4-anthraquinone (AQ code number), such as AQ8, AQ9 and AQ10, can trigger cytochrome c release without caspase activation and retain their ability to induce apoptosis in multidrug-resistant (MDR) tumor cells, fluorescent probes of transmembrane potential have been used to determine whether these anti-tumor compounds might directly target mitochondria in cell and cell-free systems to cause the collapse of mitochondrial membrane potential (/Deltapsim) that is linked to permeability transition pore (PTP) opening. Using JC-1 dye, the abilities of various AQ analogs to induce the /Deltapsim in wild-type and MDR HL-60 cells are rapid (within 2.5-10 min), irreversible after drug removal, concentration dependent in the 0.256-10 micromol/l range and generally related to their anti-tumor activities in vitro. The /Deltapsim caused by AQ9 and AQ10, which are more potent than mitoxantrone, staurosporine and the reference depolarizing agent carbonyl cyanide m-chlorophenylhydrazone (CCCP) in HL-60 cells, are not prevented by caspase-2 or -8 inhibitors, suggesting that activations of these apical caspases upstream of mitochondria are not involved in this process. Antitumor AQ analogs (0.256-10 micromol/l) also mimic the abilities of the known depolarizing agents CCCP, alamethicin, gramicidin A and 100 micromol/l CaCl2 to directly induce within 15 min the /Deltapsim in isolated mitochondria prepared from mouse liver and loaded with rhodamine 123 dye. The fact that 20 micromol/l Ca2+, which is insufficient to trigger depolarization on its own, is required to reveal the depolarizing effect of AQ9 in isolated mitochondria suggests that anti-tumor AQ analogs might interact with the PTP to alter its conformation and increase its Ca2+ sensitivity. Indeed, such Ca2+-dependent /Deltapsim of isolated mitochondria treated with 1.6 micromol/l AQ9 or 100 micromol/l Ca2+ are blocked by ruthenium red. Daunorubicin (DAU) is unable to mimic the rapid /Deltapsim caused by anti-tumor AQ analogs within 2.5-40 min of treatment in HL-60 cells or isolated mitochondria. Moreover, the /Deltapsim caused by 1.6 micromol/l AQ9 or 100 micromol/l Ca2+ in isolated mitochondria are similarly blocked by cyclosporin A (CsA), bongkrekic acid and decylubiquinone, which prevent PTP opening, suggesting that, in contrast to DAU, anti-tumor AQ analogs that directly target mitochondria to trigger the Ca2+-dependent and CsA-sensitive /Deltapsim, might induce PTP opening and the mitochondrial pathway of apoptosis even in the absence of nuclear signals.
AuthorsYang Wang, Elisabeth M Perchellet, Mary M Ward, Kaiyan Lou, Duy H Hua, Jean-Pierre H Perchellet
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 16 Issue 9 Pg. 953-67 (Oct 2005) ISSN: 0959-4973 [Print] England
PMID16162972 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Anthraquinones
  • Cysteine Proteinase Inhibitors
  • Ion Channels
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Bongkrekic Acid
  • Ruthenium Red
  • Ubiquinone
  • Gramicidin
  • Alamethicin
  • 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone
  • 1,4-anthraquinone
  • Cyclosporine
  • Mitoxantrone
  • Staurosporine
  • Calcium Chloride
  • Daunorubicin
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 (genetics)
  • Alamethicin (pharmacology)
  • Animals
  • Anthraquinones (chemistry, pharmacology)
  • Bongkrekic Acid (pharmacology)
  • Calcium Chloride (pharmacology)
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone (pharmacology)
  • Cyclosporine (pharmacology)
  • Cysteine Proteinase Inhibitors (pharmacology)
  • Daunorubicin (pharmacology)
  • Dose-Response Relationship, Drug
  • Drug Resistance, Multiple (genetics)
  • Female
  • Gramicidin (pharmacology)
  • HL-60 Cells
  • Humans
  • Intracellular Membranes (drug effects, physiology)
  • Ion Channels (antagonists & inhibitors, drug effects)
  • Membrane Potentials (drug effects)
  • Mice
  • Mitochondria (drug effects, physiology)
  • Mitochondrial Membrane Transport Proteins
  • Mitochondrial Permeability Transition Pore
  • Mitoxantrone (pharmacology)
  • Ruthenium Red (pharmacology)
  • Staurosporine (pharmacology)
  • Ubiquinone (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: